Anti-pancreatic cancer antibodies

Details for Australian Patent Application No. 2009279503 (hide)

Owner Immunomedics, Inc.

Inventors Goldenberg, David M.; Hansen, Hans J.; Chang, Chien-Hsing; Gold, David V.

Agent Davies Collison Cave

Pub. Number AU-A-2009279503

PCT Pub. Number WO2010/017500

Priority 12/343,655 24.12.08 US; 61/087,463 08.08.08 US; 61/144,227 13.01.09 US; 12/418,877 06.04.09 US

Filing date 7 August 2009

Wipo publication date 11 February 2010

International Classifications

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

A61K 51/08 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61K 51/10 (2006.01) Preparations containing radioactive substances for use in therapy or testing

Event Publications

3 February 2011 PCT application entered the National Phase

  PCT publication WO2010/017500 Priority application(s): WO2010/017500

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009279510-Solar energy conversion

2009279494-Utilizing HARQ for uplink grants received in wireless communications